Tag Archives: new drug

Seattle Gummy Company Announces Dr. Michael Jensen As Medical Advisor

allergy gummy

Hailing from Mayo Clinic, Dr. Michael Jensen is joining the Seattle Gummy Company (SGC) as a medical advisor. Dr. Jenson, who currently holds the Thomas J. Watson, Jr. Professorship in Honor of Dr. Robert L. Frye at the Mayo Clinic Alix School of Medicine, received his training in Internal Medicine, Endocrinology, and Clinical Nutrition from the Mayo […]

Seattle Gummy Company Secures The First (IND) Gummy Drug Approval From FDA

SEATTLE, Oct. 15, 2020 /PRNewswire/ — Seattle Gummy Company’s breakthrough gummy drug program, which delivers Active Pharmaceutical Ingredients (APIs) in its innovative gummy matrix, recently won its first Investigational New Drug Application (IND) approval from FDA on the company’s allergy gummy medication, designated as IND 140312. Led by founder and CEO, Dr. Connie Wan, SGC redefines a household staple […]